Three-Year Longitudinal Evaluation of Timing Effects on Subcutaneous Immunotherapy Efficacy and Safety in Allergic Rhinitis.

Clin Exp Allergy · 2025 · PMC12515532 · PMID 40325619

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

showed a trendp < 0.1so close (0.05 < p ≤ 0.1)

Notably, the AD group demonstrated significantly greater improvement in runny nose at the 6‐month follow‐up ( p < 0.05) and showed a trend towards better improvement in nasal congestion and overall visual analogue scale (VAS) scores compared with the MD group ( p < 0.1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.